The mammalian SKIV2L RNA exosome is essential for early B cell development

Kun Yang,Jie Han,Jennifer G. Gill,Jason Y. Park,Meghana N. Sathe,Jyothsna Gattineni,Tracey Wright,Christian Wysocki,M. Teresa de la Morena,Nan Yan
DOI: https://doi.org/10.1126/sciimmunol.abn2888
IF: 30.63
2022-06-04
Science Immunology
Abstract:The SKIV2L RNA exosome is an evolutionarily conserved RNA degradation complex in the eukaryotes. Mutations in the SKIV2L gene are associated with a severe inherited disorder, trichohepatoenteric syndrome (THES), with multisystem involvement but unknown disease mechanism. Here, we reported a THES patient with SKIV2L mutations showing severe primary B cell immunodeficiency, hypogammaglobulinemia, and kappa-restricted plasma cell dyscrasia but normal T cell and NK cell function. To corroborate these findings, we made B cell–specific Skiv2l knockout mice ( Skiv2l fl/fl Cd79a-Cre ), which lacked both conventional B-2 and innate-like B-1 B cells in the periphery and secondary lymphoid organs. This was linked to a requirement of SKIV2L RNA exosome activity in the bone marrow during early B cell development at the pro–B cell to large pre–B cell transition. Mechanistically, Skiv2l -deficient pro–B cells exhibited cell cycle arrest and DNA damage. Furthermore, loss of Skiv2l led to substantial out-of-frame V(D)J rearrangement of immunoglobulin heavy chain and severely reduced surface expression of μH, both of which are crucial for pre-BCR signaling and proliferative burst during early B cell development. Together, our data demonstrated a crucial role for SKIV2L RNA exosome in early B cell development in both human and mice by ensuring proper V(D)J recombination and Igh expression, which serves as the molecular basis for immunodeficiency associated with THES.
immunology
What problem does this paper attempt to address?